Literature DB >> 19687012

The pathology of Wilms' tumour (nephroblastoma): the International Society of Paediatric Oncology approach.

G M Vujanić1, B Sandstedt.   

Abstract

In the International Society of Paediatric Oncology renal tumour trials, preoperative chemotherapy has been successfully applied with resulting reduction of tumour rupture and increased favourable stage distribution of nephroblastoma. Postoperative treatment includes chemotherapy and sometimes radiotherapy in a risk-adapted approach based on histological sub-classification and stage of the tumour. However, preoperative chemotherapy alters the tumour's histological features and distribution of subtypes, and makes staging more difficult. The paper highlights the most common practical diagnostic difficulties that a pathologist is faced with in dealing with pretreated nephroblastomas. It emphasises the importance of a systematic, step-by-step analysis based on adequately sampled material, in order to accurately sub-classify a nephroblastoma as a low, intermediate or high risk tumour and assign its genuine stage. Finally, it outlines the standard operating procedure for submission of renal tumours for rapid central pathology review which allows the treating oncologists to apply the optimal treatment protocol.

Entities:  

Mesh:

Year:  2009        PMID: 19687012     DOI: 10.1136/jcp.2009.064600

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  29 in total

1.  Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.

Authors:  Gordan M Vujanić; Marco Schiavo Lena; Neil J Sebire
Journal:  Virchows Arch       Date:  2018-12-04       Impact factor: 4.064

2.  Wilms Tumor of the Ovary: Review of the Literature and Report of 2 Cases.

Authors:  Gulisa Turashvili; Daniel J Fix; Robert A Soslow; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2018-12-03       Impact factor: 2.762

3.  [Imaging of abdominal tumors in childhood and adolescence : Part II: relevant intra-abdominal and retroperitoneal tumor entities].

Authors:  D M Renz; H-J Mentzel
Journal:  Radiologe       Date:  2018-07       Impact factor: 0.635

4.  Adult urinary bladder tumors with rhabdomyosarcomatous differentiation: clinical, pathological and immunohistochemical studies.

Authors:  Zhanyong Bing; Paul J Zhang
Journal:  Diagn Pathol       Date:  2011-07-15       Impact factor: 2.644

Review 5.  Wilms' tumor- roadmaps of management.

Authors:  Yogesh Kumar Sarin; Sushmita Nitin Bhatnagar
Journal:  Indian J Pediatr       Date:  2012-05-04       Impact factor: 1.967

6.  Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster.

Authors:  Linda Holmquist Mengelbier; Jenny Karlsson; David Lindgren; Ingrid Øra; Margareth Isaksson; Ildiko Frigyesi; Attila Frigyesi; Johannes Bras; Bengt Sandstedt; David Gisselsson
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

Review 7.  International pediatric liver cancer pathological classification: current trend.

Authors:  Yukichi Tanaka; Takeshi Inoue; Hiroshi Horie
Journal:  Int J Clin Oncol       Date:  2013-10-18       Impact factor: 3.402

8.  FXR1 expression domain in Wilms tumor.

Authors:  Hannah M Phelps; Janene M Pierce; Andrew J Murphy; Hernan Correa; Jun Qian; Pierre P Massion; Harold N Lovvorn
Journal:  J Pediatr Surg       Date:  2019-02-28       Impact factor: 2.545

9.  Is the SIOP-2001 Classification of Renal Tumors of Childhood accurate with regard to prognosis? A problem revisited.

Authors:  Jerzy Niedzielski; Katarzyna Taran; Wojciech Młynarski; Anna Sitkiewicz
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

Review 10.  Wilms Tumor of the Ovary: Review of the Literature and Report of 2 Cases.

Authors:  Gulisa Turashvili; Daniel J Fix; Robert A Soslow; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2020-01       Impact factor: 3.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.